Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Melanoma 24Neoplasm Metastasis 11Skin Neoplasms 10Neoplasms 8Kidney Neoplasms 6Carcinoma, Renal Cell 4Breast Neoplasms 4Uveal Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Neuroblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2HIV Infections 2Gastrointestinal Neoplasms 2Eye Neoplasms 2Colonic Neoplasms 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Vulvar Neoplasms 1Vulvar Diseases 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 3Methotrexate 3Filgrastim 3Etoposide 3Cytarabine 3Busulfan 3sargramostim 2merphos 2Vorinostat 2Idarubicin 2Granulocyte-Macrophage Colony-Stimulating Factor 2Decitabine 2Cyclosporine 2tipifarnib 1palmitoyl-L-asparaginase 1entinostat 1bryostatin 1 1aldesleukin 1Vitamin E 1Transplantation 1Topotecan 1Thioguanine 1Thalidomide 1Tacrolimus 1Radiotherapy, Conformal 1Methylprednisolone 1Lenalidomide 1Isotretinoin 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia, Refractory × Interleukin-2 × Clear all
NCT00002798 2013-01-16

Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 3 Completed
880 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡